140 related articles for article (PubMed ID: 7171456)
1. Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer.
Staab HJ; Anderer FA; Hornung A; Stumpf E; Fischer R
Br J Cancer; 1982 Nov; 46(5):773-81. PubMed ID: 7171456
[TBL] [Abstract][Full Text] [Related]
2. [The doubling time of circulating CEA as an individual prognostic criterion of recurrence in patients with gastrointestinal cancers].
Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
Klin Wochenschr; 1986 Jan; 64(2):63-9. PubMed ID: 3951166
[TBL] [Abstract][Full Text] [Related]
3. Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease.
Staab HJ; Anderer FA
Cancer Detect Prev; 1983; 6(1-2):33-9. PubMed ID: 6883391
[TBL] [Abstract][Full Text] [Related]
4. [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy].
Takesue F; Inutsuka S; Nagahama S; Kusumoto H; Korenaga D; Maekawa S; Ikeda T
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():464-8. PubMed ID: 9589054
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of CEA in colorectal carcinoma].
Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
[TBL] [Abstract][Full Text] [Related]
6. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
[TBL] [Abstract][Full Text] [Related]
7. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas.
Umehara Y; Kimura T; Yoshida M; Oba N; Harada Y
Cancer; 1993 Jun; 71(12):4055-9. PubMed ID: 8508370
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.
Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH
Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
Jubert AV; Talbott TM; Maycroft TM
Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma.
Ito K; Hibi K; Ando H; Hidemura K; Yamazaki T; Akiyama S; Nakao A
Jpn J Clin Oncol; 2002 Feb; 32(2):54-8. PubMed ID: 11948229
[TBL] [Abstract][Full Text] [Related]
11. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
Wanebo HJ
Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
[TBL] [Abstract][Full Text] [Related]
12. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
Armitage NC; Davidson A; Tsikos D; Wood CB
Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
[TBL] [Abstract][Full Text] [Related]
13. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.
Boey J; Cheung HC; Lai CK; Wong J
World J Surg; 1984 Jun; 8(3):279-86. PubMed ID: 6464483
[No Abstract] [Full Text] [Related]
14. Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival.
Aabo K; Pedersen H; Kjaer M
Eur J Cancer Clin Oncol; 1986 Feb; 22(2):211-7. PubMed ID: 3699082
[TBL] [Abstract][Full Text] [Related]
15. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
Terabe K; Ichihashi H; Kamei H; Kondo T
Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
[TBL] [Abstract][Full Text] [Related]
16. CEA levels at recurrence and metastases; importance for detecting secondary disease.
Rieger A; Wahren B
Scand J Gastroenterol; 1975; 10(8):869-74. PubMed ID: 1202621
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
Yu BM
Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
[TBL] [Abstract][Full Text] [Related]
18. [CEA assays in postoperative detection of recurrent colorectal carcinoma (author's transl)].
Kato K; Morimoto T; Kato T; Yasue M; Takagi H; Kito T; Nakazato H; Miyaishi S; Yamada E; Kuwabara M; Suchi T
Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1137-42. PubMed ID: 7229472
[No Abstract] [Full Text] [Related]
19. Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer.
Tanaka K; Noura S; Ohue M; Seki Y; Yamada T; Miyashiro I; Ohigashi H; Yano M; Ishikawa O; Murata K; Kameyama M; Imaoka S
Dig Surg; 2008; 25(4):319-24. PubMed ID: 18818499
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
